Visiongain Publishes Autotransfusion Systems Market Report to 2031

22 February 2021

Visiongain has published a new report on Autotransfusion Systems Market Report to 2031. Profiles of Leading Autotransfusion Systems Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Autotransfusion Systems Market Report Market was valued at US $XXX billion in 2020 and is projected to reach at a market value of US$XXX billion by 2031. Autotransfusion Systems is widely used to provide autologous blood during surgical procedures. In this process autotransfusion systems allows the transfusion of the patient’s blood rather than using the banked allogenic blood. It is incredibly useful during the critical procedures such as orthopedic and cardiac surgery. It reduces the risk of transfusion-transmitted infection post-surgery.

The global Autotransfusion Systems Market is growing worldwide due to the rising adoption of surgeries such as transplant surgeries and growing heart diseases. The rising awareness campaigns, and significant government initiatives are also benefitting the global Autotransfusion Systems Market. Further, the growing healthcare expenditure, increasing disposable income, and growing awareness for diagnosis and treatment of fatal diseases will create significant opportunities for the global Autotransfusion Systems market. However, the side effects associated with the Autotransfusion Systems and high cost will affect the growth of the market.

COVID-19 Impact on the Global Autotransfusion Systems Market
The global Autotransfusion Systems market has been impacted by the COVID-19 pandemic. The COVID19 pandemic turned out to be a massive roadblock for the growth of the Autotransfusion Systems. According to worldometers, over 57.8 million cases of COVID-19 were registered till 21st November 2020, around the globe with around 1.37 million fatalities. Lockdowns for months followed by stringent social distancing norms affected the autotransfusion market. Many surgeries postponed or cancelled due to the complete lockdown and stern regulations. It affected the market growth in the first 2 quarters of 2020, however, the market is gaining momentum after the unlocking phase getting started worldwide.

Market Drivers
Rising incidence and prevalence of heart diseases
The rising incidence and prevalence rate of heart diseases such as CVD (Cardiovascular Disease), CHD (Coronary Heart Disease), Stroke, and other heart disorders are creating huge scope for the Autotransfusion Systems market. According to WHO, in 2016, around 17.9 million fatalities were registered due to CVD, representing 31% of the global fatalities. The majority living in emerging countries such as China, India, and Korea. According to American Heart Association, CVDs claim more lives every year than all forms of Cancer and Chronic Lower Respiratory Disease combined.

Rising Accidents across the world
Number of road accidents, injuries are on rise, with major cases registered in the emerging economies such as Korea, Thailand, India, and China. Autotransfusion Systems is widely used during emergency surgeries so that the blood lose can be prevented during surgeries. Rising accidental injuries and trauma will create huge demand for the autotransfusion devices. As per Safe International Road Travel, more than 1.2 million lose their life in road accidents. The occurrence of road injuries has been increased since the two wheelers and four wheelers sales have been increased many folds, leading to increased count of surgeries and continuous blood transfer.

Market Opportunities

North America will dominate the Autotransfusion Systems market

North America is expected to continue to dominate the global autotransfusion system market owing to huge adoption of autotransfusion devices due to rising surgeries. Sale of these devices are on the growing trajectory in North America due to rising incidence and prevalence rate of CVDs, CHDs, Stroke, and other heart disorders coupled with growing surgeries to treat heart patients. Additionally, the higher prevalence of heart disorders, highest healthcare expenditure and robust healthcare reforms will create demand for the autotransfusion devices in the region.

Rising Geriatric Population in the World
Huge pool of geriatric population is boosting the demand for the treatment for the Autotransfusion Systems. Older population are more likely to get expose to heart diseases, obesity, and other health issues due to old age. The lifestyle changes and poor dietary habits has further affected the older population across the world.

Competitive Landscape
Visiongain report covers detailed competitive landscape which includes overview of key players operating, extensive product portfolios, recent developments, among others. Some of the company’s profiled in this report include Some of the company’s profiled in this report are Becton, Dickinson and Company, Medtronic PLC, Zimmer Biomet Holdings, Inc, LivaNova, Fresenius, Atrium Medical Corporation, Teleflex Inc, Haemonetics Corporation, Sarstedt, Inc., among others. The global Autotransfusion Systems market players adopt various strategies to cater the available opportunities in the market. Mergers & acquisitions, partnerships, collaborations, among others, are the key strategies adopted by the market players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021


Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021


Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021


Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021